Cargando…

Formoterol in the treatment of experimental cancer cachexia: effects on heart function

BACKGROUND AND AIMS: Formoterol is a highly potent β2-adrenoceptor-selective agonist, which is a muscle growth promoter in many animal species, resulting in skeletal muscle hypertrophy. Previous studies carried out in our laboratory have shown that formoterol treatment in tumour-bearing animals resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toledo, Míriam, Springer, Jochen, Busquets, Sílvia, Tschirner, Anika, López-Soriano, Francisco J., Anker, Stefan D., Argilés, Josep M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248407/ https://www.ncbi.nlm.nih.gov/pubmed/25167857 http://dx.doi.org/10.1007/s13539-014-0153-y

Ejemplares similares

Theophylline is able to partially revert cachexia in tumour-bearing rats
por: Olivan, Mireia, et al.
Publicado: (2012)

Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3
por: Toledo, Míriam, et al.
Publicado: (2014)

Cachexia: a problem of energetic inefficiency
por: Argilés, Josep M., et al.
Publicado: (2014)

Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise
por: Penna, Fabio, et al.
Publicado: (2011)

The cachexia score (CASCO): a new tool for staging cachectic cancer patients
por: Argilés, Josep M., et al.
Publicado: (2011)

Nonmuscle Tissues Contribution to Cancer Cachexia
por: Argilés, Josep M., et al.
Publicado: (2015)

Therapeutic strategies against cancer cachexia
por: Argilés, Josep M., et al.
Publicado: (2019)

The animal cachexia score (ACASCO)
por: Betancourt, Angelica, et al.
Publicado: (2019)

Optimal management of cancer anorexia–cachexia syndrome
por: Argilés, Josep M, et al.
Publicado: (2010)

Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011)

Are there any benefits of exercise training in cancer cachexia?
por: Argilés, Josep M., et al.
Publicado: (2012)

The atypical β‐blocker S‐oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model
por: Yuan, Luping, et al.
Publicado: (2022)

Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats
por: Salazar-Degracia, Anna, et al.
Publicado: (2017)

Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
por: Springer, Jochen, et al.
Publicado: (2023)

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancies
por: Tschirner, Anika, et al.
Publicado: (2012)

A multifactorial anti‐cachectic approach for cancer cachexia in a rat model undergoing chemotherapy
por: Toledo, Míriam, et al.
Publicado: (2015)

Febuxostat improves outcome in a rat model of cancer cachexia
por: Konishi, Masaaki, et al.
Publicado: (2015)

MT‐102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia
por: Pötsch, Mareike S., et al.
Publicado: (2020)

Influence of cancer cachexia on drug liver metabolism and renal elimination in rats
por: Cvan Trobec, Katja, et al.
Publicado: (2015)

Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?
por: Toledo, Míriam, et al.
Publicado: (2011)

Lack of Synergy Between β-Agonist Treatment and a Blockage of Sarcoplasmic Calcium Flow in a Rat Cancer Cachexia Model
por: Busquets, Silvia, et al.
Publicado: (2021)

Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation
por: Musolino, Vincenzo, et al.
Publicado: (2016)

Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool
por: Argilés, Josep M., et al.
Publicado: (2017)

Cachexia in heart disease: highlights from the ESC 2010
por: Kung, Thomas, et al.
Publicado: (2011)

Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer
por: Madeddu, Clelia, et al.
Publicado: (2023)

Six1 is down‐regulated in end‐stage human dilated cardiomyopathy independently of Ezh2
por: Tschirner, Anika, et al.
Publicado: (2015)

Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations
por: Pin, Fabrizio, et al.
Publicado: (2015)

Nutrition in cachexia: from bench to bedside
por: Konishi, Masaaki, et al.
Publicado: (2016)

Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model
por: Tzika, A. Aria, et al.
Publicado: (2013)

Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology
por: Anker, Markus S., et al.
Publicado: (2013)

Cardiac cachexia: hic et nunc
por: Loncar, Goran, et al.
Publicado: (2016)

Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact
por: Konishi, Masaaki, et al.
Publicado: (2016)

The 10th year of the Journal of Cachexia, Sarcopenia and Muscle
por: Anker, Markus S., et al.
Publicado: (2020)

Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia
por: CONSTANTINOU, CATERINA, et al.
Publicado: (2011)

Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance
por: Busquets, Sílvia, et al.
Publicado: (2011)

Open source in cachexia?
por: Stemmler, Britta, et al.
Publicado: (2015)

The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats
por: Pötsch, Mareike S., et al.
Publicado: (2013)

IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia
por: Schmidt, Katja, et al.
Publicado: (2011)

A Rat Immobilization Model Based on Cage Volume Reduction: A Physiological Model for Bed Rest?
por: Marmonti, Enrica, et al.
Publicado: (2017)

Clinical problems of patients with cachexia due to chronic illness: a congress report
por: Hadzibegovic, Sara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e8kjoau2499mes8n32fhlepais